ID   WAe001-A-19
AC   CVCL_VF82
SY   H1-RB1(E16)-/+; CDMLe001-A; CDMLe004-A-19
DR   hPSCreg; WAe001-A-19
DR   SKIP; SKIP003207
DR   Wikidata; Q54993552
RX   PubMed=29414415;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 9884; RB1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29414415
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
RX   PubMed=29414415; DOI=10.1016/j.scr.2018.01.021;
RA   Tu J., Huo Z.-J., Liu M., Wang D.-H., Xu A., Zhou R.-J., Zhu D.-D.,
RA   Gingold J.A., Shen J.-N., Zhao R.-Y., Lee D.-F.;
RT   "Generation of human embryonic stem cell line with heterozygous RB1
RT   deletion by CRIPSR/Cas9 nickase.";
RL   Stem Cell Res. 28:29-32(2018).
//